跳至主要内容
临床试验/EUCTR2011-001510-33-GB
EUCTR2011-001510-33-GB进行中(未招募)1 期

The Efficacy of Continuous Intra-articular Infusion of Local Anaesthetic Agent following Elective Primary Hip Arthroplasty - LIA Hip Study

eeds Teaching Hospitals R and D department0 个研究点目标入组 90 人开始时间: 2012年8月21日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Men and women aged 18-99 • ASA 1-3 • Able to give informed consent • Fit to undergo elective primary total hip arthroplasty
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 42
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 28

排除标准

  • Any patient already taking opioid analgesia or NSAIDs including aspirin • Allergy/sensitivity to local anaesthetics agents • Allergy/sensitivity to NSAIDs • Allergy/sensitivity to adrenaline • Patients taking anti-coagulant medication • Severe liver disease • Severely impaired renal function • Severe heart failure • Active cerebrovascular bleeding • Severe coagulation disorders • Severe asthma or previous bronchospasm with NSAIDs • Porphyria • Active peptic ulcer disease or acute GI bleed • Any patient unable to consent or understand the pump function • Bilateral hip replacements • Pregnancy/lactation (routine pregnancy tests are carried out pre-operatively on all patients of child bearing age) • Any patient already enrolled in another study

研究者

发起方
eeds Teaching Hospitals R and D department

相似试验